We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

209 hedge funds and large institutions have $1.65B invested in Sage Therapeutics in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 62 increasing their positions, 71 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $19.2M | Put options by funds: $12.5M

1.73% more ownership

Funds ownership: 84.58% → 86.31% (+1.7%)

6% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 36

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% less capital invested

Capital invested by funds: $1.65B → $1.65B (-$4.65M)

1% less funds holding

Funds holding: 211 → 209 (-2)

13% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 71

Holders
209
Holders Change
-2
Holders Change %
-0.95%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
38
Increased
62
Reduced
71
Closed
36
Calls
$19.2M
Puts
$12.5M
Net Calls
+$6.67M
Net Calls Change
+$3.46M

Top Buyers

1
BlackRock
BlackRock
New York
+$49.9M
2
Marshall Wace
Marshall Wace
United Kingdom
+$32.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$27.4M
4
Goldman Sachs
Goldman Sachs
New York
+$26.6M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$16.2M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$75.3M
2
First Trust Advisors
First Trust Advisors
Illinois
-$28M
3
DTC
Deep Track Capital
Connecticut
-$16.9M
4
AG
Artal Group
Luxembourg
-$10.1M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$9.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
FF
176
FourThought Financial
Florida
$4K – – –
LJHT
177
Laurie J. Hall Trustee
$4K – – –
TWC
178
TD Waterhouse Canada
Ontario, Canada
$3.23K – – –
FWM
179
Focused Wealth Management
New York
$3K – – –
KTC
180
Kistler-Tiffany Companies
Pennsylvania
$3K – – –
SSB
181
Sandy Spring Bank
Maryland
$3K – – –
HNWAG
182
High Net Worth Advisory Group
Florida
$3K +$3.35K +100 New
LWCFA
183
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$2K – – –
SPIA
184
Steward Partners Investment Advisory
New York
$2K – – –
QCG
185
Quadrant Capital Group
Ohio
$2K +$1.41K +42 +168%
BTI
186
Blue Trust Inc
Georgia
$2K +$1.64K +49 New
CA
187
Crewe Advisors
Utah
$2K +$1.84K +55 New
Bank of Montreal
188
Bank of Montreal
Ontario, Canada
$1.49K +$1.06M +31,713 +327%
Carson Wealth (CWM LLC)
189
Carson Wealth (CWM LLC)
Nebraska
$1K -$1.11K -33 -52%
MAM
190
Meeder Asset Management
Ohio
$1K -$302 -9 -21%
BHWM
191
Beaird Harris Wealth Management
Texas
$1K – – –
EARNEST Partners
192
EARNEST Partners
Georgia
$1K – – –
NFSG
193
Newbridge Financial Services Group
Florida
$1K – – –
QC
194
Quent Capital
New York
$1K – – –
BIA
195
Bell Investment Advisors
California
$1K +$1.07K +32 New
TC
196
Truvestments Capital
Florida
$1K +$1.31K +39 New
ED
197
Exane Derivatives
France
$452 – – –
WIM
198
Westside Investment Management
California
$22 – – –
First Trust Advisors
199
First Trust Advisors
Illinois
– -$28M -844,652 Closed
IC
200
Ikarian Capital
Texas
– -$8.38M -249,907 Closed
6 7
8
9 10

SAGE Hedge Fund Activity: Q2 2022 in Review

209 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q2 2022, worth a combined $1.65B — down 0.28% from $1.65B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new SAGE positions and 36 closed out — a net gain of 2 holders — while 62 added to existing stakes and 71 trimmed.

The largest buyer was BlackRock, adding an estimated $49.9M. The largest seller was Wellington Management Group, cutting an estimated $75.3M.

  • 209 institutional investors held Sage Therapeutics (SAGE) as of Q2 2022, down from 211 in Q1 2022.
  • Funds reported $1.65B of Sage Therapeutics stock for Q2 2022, down 0.28% quarter-over-quarter.
  • 38 funds opened new Sage Therapeutics positions in Q2 2022 and 36 closed out, a net change of +2 holders.
  • The largest Sage Therapeutics buyer in Q2 2022 was BlackRock, an estimated $49.9M added.
  • The largest Sage Therapeutics seller in Q2 2022 was Wellington Management Group, an estimated $75.3M sold.

Based on aggregated 13F filings for Q2 2022.